[HTML][HTML] Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity

S Barsi, H Papp, A Valdeolivas, DJ Tóth… - PLoS computational …, 2022 - journals.plos.org
Comparing SARS-CoV-2 infection-induced gene expression signatures to drug treatment-
induced gene expression signatures is a promising bioinformatic tool to repurpose existing …

Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity

S Barsi, H Papp, AV Urbelz, DJ Tóth, A Kuczmog… - bioRxiv, 2021 - biorxiv.org
Abstract Comparing SARS-CoV-2 infection-induced gene expression signatures to drug
treatment-induced gene expression signatures is a promising bioinformatic tool to repurpose …

[PDF][PDF] Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity

S Barsi, H Papp, AV Urbelz, DJ Tóth, A Kuczmog… - scholar.archive.org
Abstract Comparing SARS-CoV-2 infection-induced gene expression signatures to drug
treatment-induced gene expression signatures is a promising bioinformatic tool to repurpose …

[PDF][PDF] Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity

S Barsi, H Papp, A Valdeolivas, DJ Tóth… - PLoS Comput …, 2022 - scienceopen.com
Abstract Comparing SARS-CoV-2 infection-induced gene expression signatures to drug
treatmentinduced gene expression signatures is a promising bioinformatic tool to repurpose …

Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity.

S Barsi, H Papp, A Valdeolivas… - PLoS …, 2022 - search.ebscohost.com
Abstract Comparing SARS-CoV-2 infection-induced gene expression signatures to drug
treatment-induced gene expression signatures is a promising bioinformatic tool to repurpose …

Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity

A Kuczmog, M Madai, L Hunyady… - PLoS Computational …, 2022 - search.proquest.com
Abstract Comparing SARS-CoV-2 infection-induced gene expression signatures to drug
treatment-induced gene expression signatures is a promising bioinformatic tool to repurpose …

[HTML][HTML] Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity

S Barsi, H Papp, AV Urbelz, DJ Tóth, A Kuczmog… - 2021 - europepmc.org
Abstract Comparing SARS-CoV-2 infection-induced gene expression signatures to drug
treatment-induced gene expression signatures is a promising bioinformatic tool to repurpose …

Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity.

S Barsi, H Papp, A Valdeolivas, DJ Tóth, A Kuczmog… - 2022 - cabidigitallibrary.org
Abstract Comparing SARS-CoV-2 infection-induced gene expression signatures to drug
treatment-induced gene expression signatures is a promising bioinformatic tool to repurpose …

[HTML][HTML] Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity

S Barsi, H Papp, A Valdeolivas, DJ Tóth… - PLoS Computational …, 2022 - ncbi.nlm.nih.gov
Abstract Comparing SARS-CoV-2 infection-induced gene expression signatures to drug
treatment-induced gene expression signatures is a promising bioinformatic tool to repurpose …

Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity

S Barsi, H Papp, A Valdeolivas… - PLoS …, 2022 - pubmed.ncbi.nlm.nih.gov
Comparing SARS-CoV-2 infection-induced gene expression signatures to drug treatment-
induced gene expression signatures is a promising bioinformatic tool to repurpose existing …